Immune-based therapies: a review of clinical endpoints used in trials of selected immunologic agents.
D023241:Antiretroviral Therapy, Highly Active; D017277:Drug Approval; D023381:Endpoint Determination / Q000592:standards*; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012107:Research Design; D014481:United States